Hancock Whitney Corp Exelixis, Inc. Transaction History

Hancock Whitney Corp

$2.92 Billion
Q2 2024

A detailed history of Hancock Whitney Corp transactions in Exelixis, Inc. stock. As of the latest transaction made, Hancock Whitney Corp holds 42,818 shares of EXEL stock, worth $1.11 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

42,818

Previous 48,212 11.19%

Holding current value

$1.11 Million

Previous $1.14 Million 15.91%

% of portfolio

0.03%

Previous 0.04%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$20.34 - $23.73 $109,713 - $127,999	-5,394 Reduced 11.19%	42,818 $962,000
Q1 2024 May 16, 2024	SELL	$20.17 - $23.93 $60,832 - $72,172	-3,016 Reduced 5.89%	48,212 $1.14 Million
Q4 2023 Feb 14, 2024	SELL	$19.25 - $24.13 $1,713 - $2,147	-89 Reduced 0.17%	51,228 $1.23 Million
Q3 2023 Nov 13, 2023	BUY	$19.04 - $22.74 $977,075 - $1.17 Million	51,317 New	51,317 $1.12 Million
Q3 2021 Nov 04, 2021	SELL	$16.3 - $21.14 $4.38 Million - $5.68 Million	-268,629 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$17.95 - $25.56 $1.4 Million - $1.99 Million	77,729 Added 40.72%	268,629 $4.89 Million
Q1 2021 May 14, 2021	BUY	$20.53 - $25.22 $1.45 Million - $1.78 Million	70,649 Added 58.75%	190,900 $4.31 Million
Q4 2020 Feb 09, 2021	SELL	$18.39 - $24.8 $533,769 - $719,820	-29,025 Reduced 19.44%	120,251 $2.41 Million
Q3 2020 Nov 05, 2020	SELL	$20.67 - $26.94 $138,364 - $180,336	-6,694 Reduced 4.29%	149,276 $3.65 Million
Q2 2020 Jul 30, 2020	BUY	$16.46 - $27.42 $2.57 Million - $4.28 Million	155,970 New	155,970 $3.7 Million
Q4 2019 Feb 06, 2020	SELL	$15.15 - $18.89 $819,251 - $1.02 Million	-54,076 Closed	0 $0
Q3 2019 Oct 29, 2019	SELL	$17.68 - $22.65 $24,805 - $31,777	-1,403 Reduced 2.53%	54,076 $956,000
Q2 2019 Aug 29, 2019	SELL	$18.93 - $24.75 $196,682 - $257,152	-10,390 Reduced 15.77%	55,479 $1.19 Million
Q1 2019 May 13, 2019	BUY	$19.6 - $24.76 $1.29 Million - $1.63 Million	65,869 New	65,869 $1.57 Million

Others Institutions Holding EXEL

# of Institutions

460

Shares Held

240M

Call Options Held

2.04M

Put Options Held

1.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $8.35B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.

Account

Hancock Whitney Corp Exelixis, Inc. Transaction History